A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes

Emerging Infectious Diseases

Volumn 15, Issue 10, 2009, Pages 1547-1555

  Van Den Dool, Carline ^a   Hak, Eelko ^a,b   Bonten, Marc J M ^a   Wallinga, Jacco ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ANTIVIRAL RESISTANCE; ARTICLE; DRUG EFFICACY; HEALTH CARE PERSONNEL; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; LONG TERM CARE; NURSING HOME; STOCHASTIC MODEL; VIRUS TRANSMISSION;

AGED; ANTIVIRAL AGENTS; DISEASE OUTBREAKS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; NURSING HOMES; OSELTAMIVIR;

EID: 70349976811     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1510.081129     Document Type: Article

References (38)

1. Cools HJ, van Essen GA. Practice guideline "Influenza prevention in nursing homes and care homes," issued by the Dutch Society of Nursing Home Specialists; division of tasks between nursing home specialist, general practitioner and company doctor [in Dutch]. Ned Tijdschr Geneeskd. 2005;149:119-124
2. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008;57:1-60.
3. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ. 2003;326:1235. DOI: 10.1136/ bmj.326.7401.1235 (Pubitemid 36688077)
4. Halloran ME, Hayden FG, Yang Y, Longini IM Jr, Monto AS. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol. 2007;165:212-221 DOI: 10.1093/aje/kwj362 (Pubitemid 46096383)
5. Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis. 2004;189:440-449 DOI: 10.1086/381128 (Pubitemid 38210580)
6. Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001;285:748-754 DOI: 10.1001/jama.285.6. 748 (Pubitemid 32167233)
7. Peters PH, Jr., Gravenstein S, Norwood P, De B, V, Van Couter A, Gibbens M, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc. 2001;49:1025-1031 DOI: 10.1046/j.1532-5415.2001.49204.x (Pubitemid 32801138)
8. Monto AS, Rotthoff J, Teich E, Herlocher ML, Truscon R, Yen HL, et al. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis. 2004;39:459-464 DOI: 10.1086/422646 (Pubitemid 39120917)
9. Bowles SK, Lee W, Simor AE, Vearncombe M, Loeb M, Tamblyn S, et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc. 2002;50:608-616 DOI: 10.1046/j.1532-5415.2002.50153.x
10. Parker R, Loewen N, Skowronski D. Experience with oseltamivir in the control of a nursing home influenza B outbreak. Can Commun Dis Rep. 2001;27:37-40.
11. Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, et al. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill. 2008;13:8026.
12. Moscona A. Global transmission of oseltamivir-resistant influenza. N Engl J Med. 2009;360:953-956 DOI: 10.1056/NEJMp0900648
13. Enserink M. Infectious disease. Old drugs losing effectiveness against flu; could statins fill gap? Science. 2005;309:1976-1977 DOI: 10.1126/science.309.5743.1976a
14. Stilianakis NI, Perelson AS, Hayden FG. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. J Infect Dis. 1998;177:863-873
15. Longini IM Jr, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol. 2004;159:623-633 DOI: 10.1093/aje/kwh092 (Pubitemid 38405377)
16. CTG ZAio. Doelmatigheid verpleeghuizen in relatie tot verantwoorde zorg onderzocht. 21-26-2006. Utrecht, CTG/ZAio [Dutch Healthcare Authority] [cited 2009 Jul 29]. Available from http:// www.nza.nl/7113/10118/10124
17. Tekstproducties JCM. Arcares jaarverslag 2005. Utrecht (the Netherlands): Arcares; 2006.
18. van den Dool C, Bonten MJ, Hak E, Heijne JC, Wallinga J. The effects of influenza vaccination of health care workers in nursing homes: insights from a mathematical model. PLoS Med. 2008;5:e200. DOI: 10.1371/journal.pmed.0050200
19. Anderson R, May RM. Infectious diseases of humans: dynamics and control. New York: Oxford University Press; 1991.
20. Hirotsu N, Ikematsu H, Iwaki N, Kawai N, Shigematsu T, Kunishima O, et al. Effects of antiviral drugs on viral detection in influenza patients and on the sequential infection to their family members - serial examination by rapid diagnosis (Capilia) and virus culture. Int Congr Ser. 2004;1263:105-108 DOI: 10.1016/j.ics.2004.02.020
21. Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci. 2007;274:599-604. DOI: 10.1098/rspb.2006.3754 (Pubitemid 47055535)
22. Cauchemez S, Valleron AJ, Boelle PY, Flahault A, Ferguson NM. Estimating the impact of school closure on influenza transmission from sentinel data. Nature. 2008;452:750-754 DOI: 10.1038/ nature06732
23. Webster RG. Immunity to influenza in the elderly. Vaccine. 2000;18:1686-1689 DOI: 10.1016/S0264-410X(99)00507-1
24. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine. 2007;25:3066-3069 DOI: 10.1016/j.vaccine.2007.01.025
25. Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006;333:1241. DOI: 10.1136/bmj.39010.581354.55 (Pubitemid 46032352)
26. Lipsitch M, Cohen T, Murray M, Levin BR. Antiviral resistance and the control of pandemic influenza. PLoS Med. 2007;4:e15. DOI: 10.1371/journal.pmed. 0040015 (Pubitemid 46191826)
27. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007;CD001269.
28. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366:1165-1174 DOI: 10.1016/S0140-6736(05)67339-4 (Pubitemid 41393594)
29. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357:1373-1381 DOI: 10.1056/NEJMoa070844 (Pubitemid 47535592)
30. Chik KW, Li CK, Chan PK, Shing MM, Lee V, Tam JS, et al. Oseltamivir prophylaxis during the influenza season in a paediatric cancer centre: prospective observational study. Hong Kong Med J. 2004;10:103-106 DOI: 10.1016/S1561-5413(09)60167-8 (Pubitemid 38477922)
31. de Klerk M. Ouderen in Instellingen. Landelijk overzicht van de leefsituatie van oudere tehuisbewoners (7), 26-29. 2005. Den Haag, Sociaal en Cultureel Planbureau [The Netherlands Institute for Social Research] [cited 2009 Jul 29]. Available from http://www.scp. nl/dsresource?objectid=20740&type= org
32. Kingston BJ, Wright CV Jr. Influenza in the nursing home. Am Fam- Physician. 2002;65:75-8, 72.
33. Looijmans-van den Akker I, van Delden JJ, Hak E. Uptake of in- fluenza vaccination in Dutch nursing home personnel following national recommendations. J Am Geriatr Soc. 2007;55:1486-1487 DOI: 10.1111/j.1532-5415.2007.01277.x (Pubitemid 47329221)
34. Finkelman BS, Viboud C, Koelle K, Ferrari MJ, Bharti N, Grenfell BT. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS One. 2007;2:e1296. DOI: 10.1371/journal. pone.0001296
35. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667-1672 DOI: 10.1001/archinte.163.14.1667 (Pubitemid 36898954)
36. Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, Schwieger B, et al. Oseltamivir-resistant influenza A (H1N1), Europe, 2007-08 season. Emerg Infect Dis. 2009;15:552-560 DOI: 10.3201/eid1504.081280
37. Moscona A. Oseltamivir resistance-disabling our influenza defenses. N Engl J Med. 2005;353:2633-2636 DOI: 10.1056/NEJMp058291 (Pubitemid 41817709)
38. Wu JT, Leung GM, Lipsitch M, Cooper BS, Riley S. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Med. 2009;6:e1000085. DOI: 10.1371/journal.pmed.1000085